| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,042.70
|
|
Change (%)
|
54.10 (2.72%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,013.00
-
2,055.00
|
|
52-Week Range (RS)
|
1,774.00
-
2,403.45
|
|
Beta (1 Year)
|
0.80
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap, BSE Shariah 50, bse carbonex |
| News |
|
Corporate Details |
| Lupin receives ESG rating of 59 |
| Lupin Ltd spurts 0.51%, gains for fifth straight session |
| Lupin Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Lupin Ltd - Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Lupin Ltd - Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Lupin Ltd - Lupin Limited - Updates |
| Lupin's Aurangabad unit completes product-specific pre-approval USFDA inspection |
| Lupin's Aurangabad-based facility gets two observations from US FDA |
| Lupin Ltd - U.S. FDA Has Conducted A Product-Specific Pre-Approval Inspection At The CompanyS Chhatrapati Sambhajinagar ... |
| Lupin receives USFDA approval for Risperidone for extended-release injectable suspension |
|
|
|
| Incoporation Year : 1983 |
| Chairman : M D Gupta |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055 |
Phone:91-22-6640 2323
Fax:91-22-6640 8131 |
| E-Mail : investorservices@lupinpharma.com |
URL : https://www.lupin.com
|
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
05-Sep-2025 |
1944.65 |
5.04 |
| 1Month |
12-Aug-2025 |
1943.80 |
5.09 |
| 3Month |
12-Jun-2025 |
2022.15 |
1.02 |
| 6Month |
12-Mar-2025 |
1965.20 |
3.94 |
| 1Year |
12-Sep-2024 |
2246.85 |
-9.09 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Balanced Advantage Fund |
1.06 |
1066.94 |
| HDFC Large Cap Fund |
2.32 |
874.68 |
| HDFC Flexi Cap Fund |
0.97 |
795.86 |
| Mirae Asset Large & Midcap Fund |
1.52 |
606.82 |
| ICICI Pru Value Fund |
1.00 |
535.01 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,616.25 |
0.41 |
1,960.20 |
1,555.00 |
387,792.51 |
| Cipla Ltd |
1,573.80 |
0.83 |
1,702.00 |
1,310.05 |
127,124.34 |
| Dr Reddys Laboratories Ltd |
1,316.40 |
1.00 |
1,404.60 |
1,025.90 |
109,867.70 |
| Mankind Pharma Ltd |
2,579.85 |
-0.65 |
3,050.00 |
2,115.50 |
106,485.50 |
| Zydus Lifesciences Ltd |
1,044.85 |
0.13 |
1,135.95 |
797.05 |
105,136.36 |
|
|
|
|